Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MIMEDX GROUP, INC. Director's Dealing 2020

Dec 18, 2020

32206_dirs_2020-12-18_cdb1cbed-997c-492a-9338-a004875d123d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2020-12-16

Reporting Person: Giuliani Michael J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-16 Common Stock A 22349 $7.83 Acquired 22349 Direct
2020-12-16 Common Stock A 11174 $7.83 Acquired 33523 Direct

Footnotes

F1: Grant of restricted stock which vests in equal parts over three years from the date of the grant.

F2: Grant of restricted stock which vests in full on the earlier of one year from the grant date or on the date of the Company's next Annual Shareholders Meeting.